STAAR Surgical's go-shop period expires with no competing bids

STAAR Surgical Company (NASDAQ: STAA) announced that its go-shop period under the merger agreement with Alcon Inc. (SIX/NYSE: ALC) expired on December 6, 2025, with no competing acquisition proposals received.

During the go-shop period, STAAR engaged with 21 potential bidders, including financial sponsors and strategic acquirers. Only two parties signed non-disclosure agreements and received due diligence information, but none submitted competing offers.

The company worked with financial advisor Citi to actively solicit proposals from third parties during the process. STAAR had previously identified three parties as potential bidders in its proxy statement, but none of these parties signed non-disclosure agreements to receive company information.

Broadwood Partners, L.P. had alleged that multiple parties were interested in acquiring STAAR and that the board ignored inbound interest. STAAR stated the go-shop results counter these allegations.

"The STAAR Board conducted a thoughtful sale process before the transaction was announced that was based on its extensive M&A experience, careful consideration of potential alternatives and its informed view of the ophthalmic space," said Stephen Farrell, CEO of STAAR.

STAAR originally announced its merger agreement with Alcon in August 2025. The Lake Forest, California-based company specializes in implantable phakic intraocular lenses for vision correction and has sold more than 3 million of its Implantable Collamer Lenses in over 75 countries.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Peraso CFO James Sullivan resigns effective October 2026
• Vertical Data agrees to buy 4.5 MW Sweden data center site